Fairmount Funds Management LLC

13F Portfolio Filings

Most recent 13F
Q3 2026
Location
West Conshohocken, PA
CIK
0001802528
All SEC filings
View on sec.gov
Holdings Value, Excluding Options
Quarter Holdings Value, Excl. Options ($000) Top Holdings Form Type Date Filed Filing ID
Q3 2026 12 1,594,520 ORKA, KRSA, DNTH, DMRA 13F-HR 11/16/2026 000110465926128188
Q2 2026 12 1,512,968 ORKA, DNTH, DMRA, COGT 13F-HR 8/14/2026 000110465926096405
Q1 2026 12 1,384,339 DMRA, DNTH, COGT, SYRE 13F-HR 5/15/2026 000110465926062419
Q4 2025 13 1,313,784 COGT, APGE, SYRE, VRDN 13F-HR 2/17/2026 000110465926016303
Q3 2025 17 1,111,423 DNTH, COGT, AXSM, APGE 13F-HR 11/14/2025 000110465925112427
Q2 2025 17 771,902 APGE, AXSM, ELVN, SRRK 13F-HR 8/14/2025 000110465925078521
Q1 2025 15 644,621 AXSM, APGE, SYRE, ELVN 13F-HR 5/15/2025 000110465925049337
Q4 2024 17 1,005,884 AXSM, NUVL, SYRE, APGE 13F-HR 2/14/2025 000110465925014003
Q3 2024 15 1,233,275 AXSM, NUVL, APGE, SYRE 13F-HR 11/14/2024 000110465924118833
Q2 2024 13 885,124 AXSM, NUVL, SYRE, APGE 13F-HR 8/14/2024 000110465924089572
Q1 2024 15 917,386 AXSM, NUVL, APGE, DNTH 13F-HR 5/15/2024 000110465924061870
Q4 2023 16 946,456 AXSM, IMGN, NUVL, APGE 13F-HR 2/14/2024 000110465924023531
Q3 2023 20 831,173 AXSM, NUVL, IMGN, APGE 13F-HR 11/14/2023 000110465923118043
Q2 2023 17 709,302 AXSM, NUVL, IMGN, ELVN 13F-HR 8/14/2023 000110465923091264
Q1 2023 16 581,469 AXSM, NUVL, VRNA, ONC 13F-HR 5/15/2023 000110465923060312
Q4 2022 16 630,363 AXSM, NUVL, VRNA, ONC 13F-HR 2/14/2023 000110465923021407
Q3 2022 27 542,122 AXSM, COGT, NUVL, BCRX 13F-HR 11/9/2022 000110465922116268
Q2 2022 27 436,929 BHVN, AXSM, BCRX, GBT 13F-HR 8/15/2022 000110465922091338
Q1 2022 22 422,935 INSM, GBT, ARGX, AXSM 13F-HR 5/16/2022 000180252822000004
Q4 2021 20 303,335 ZGNX, INSM, ENTA, ARGX 13F-HR 2/14/2022 000180252822000002
Q3 2021 20 274,991 INSM, ZGNX, NUVL, ALLK 13F-HR 11/15/2021 000180252821000008
Q2 2021 19 243,235 INSM, ZGNX, AXSM, ARGX 13F-HR 8/13/2021 000180252821000007
Q1 2021 21 237,245 INSM, ZGNX, IOVA, ALLK 13F-HR 5/14/2021 000180252821000005
Q4 2020 18 279,600 INSM, FOLD, IOVA, ACAD 13F-HR 2/12/2021 000180252821000002
Q3 2020 17 236,102 INSM, ACAD, TRIL, FOLD 13F-HR 11/12/2020 000180252820000011
Q2 2020 14 224,208 ACAD, INSM, ZGNX, FOLD 13F-HR 8/4/2020 000180252820000008
Q1 2020 14 164,882 ACAD, ZGNX, INSM, IOVA 13F-HR 5/8/2020 000180252820000006
Q4 2019 15 164,989 ZGNX, INSM, ACAD, AMRN 13F-HR 2/12/2020 000180252820000004

13D and 13G Filings

All 13D and 13G filings

Each security where the latest filing since 12/18/2024 is a 13D, newest first.

Issuer % of Class Filed
Mentari Therapeutics, Inc. 13D
587157108
20.0% 11/12/2026
Event 11/6/2026
Alaunos Therapeutics, Inc. 13D
TCRT · 98973P309
20.0% 10/15/2026
Event 10/13/2026
Spyre Therapeutics, Inc. 13D/A
SYRE · 00773J202
10.0% 10/9/2026
Event 10/7/2026
Korsana Biosciences, Inc. 13D
KRSA · 23255M303
20.0% 9/11/2026
Event 9/8/2026
Crescent Biopharma, Inc. 13D/A
CBIO · G2545C104
16.5% 7/20/2026
Event 7/16/2026
Oruka Therapeutics, Inc. 13D/A
ORKA · 687604108
19.5% 7/1/2026
Event 7/1/2026
Jade Biosciences, Inc. 13D/A
JBIO · 008064206
20.0% 6/9/2026
Event 6/5/2026
Viridian Therapeutics, Inc.\DE 13D/A
VRDN · 92790C104
14.0% 5/13/2026
Event 5/11/2026
Cogent Biosciences, Inc. 13D/A
COGT · 19240Q201
8.6% 3/31/2026
Event 3/31/2026
Galecto, Inc. 13D/A
DMRA · 36322Q206
20.0% 2/11/2026
Event 2/9/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Apogee Therapeutics, Inc. 13D/A
APGE · 03770N101
0% 9/3/2026
Event 9/3/2026
Dianthus Therapeutics, Inc. 13D/A
DNTH · 252828108
4.9% 11/25/2025
Event 11/21/2025

5 other securities where the latest filing is a 13G, the newest filed 5/15/2026. View all